Literature DB >> 7891129

Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms.

C S Colwell1, M S Levine.   

Abstract

The purpose of the present study was to examine whether cAMP-dependent mechanisms regulated excitatory synaptic transmission in the neostriatum. A brain slice preparation was utilized for intracellular recordings of the excitatory postsynaptic potentials (EPSPs) evoked by electrical stimulation. Bath application of forskolin, an activator of adenylate cyclase, enhanced the EPSP amplitude and duration. This potentiation was dose dependent and did not occur with the inactive analog 1,9-dideoxyforskolin. Forskolin potentiation was unaltered by treatment with the GABAA receptor antagonist bicuculline. Furthermore, two inhibitors of cAMP-dependent protein kinase (PKA), Rp-cAMPS and IP20-amide, attenuated forskolin's enhancement of the EPSP. In addition, the PKA activator Sp-cAMPS enhanced excitatory synaptic transmission. Interestingly, treatment with PKA inhibitors alone depressed while the phosphatase inhibitor okadaic acid enhanced the synaptic response. These results suggest a role for tonic kinase and phosphatase activity in regulating excitatory synaptic transmission in the neostriatum. Finally, forskolin was found to enhance the responses of neostriatal neurons to glutamate receptor agonists. This potentiation, which occurred in the presence of tetrodotoxin, provides at leas part of the explanation for the cAMP/PKA-dependent regulation of the EPSP. Overall, these results suggest a role for the adenylate cyclase cascade in the regulation of excitatory synaptic transmission in the neostriatum.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891129      PMCID: PMC6578147     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

1.  Rhythmic coupling among cells in the suprachiasmatic nucleus.

Authors:  C S Colwell
Journal:  J Neurobiol       Date:  2000-06-15

Review 2.  Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases.

Authors:  R Tapia; F Peña; C Arias
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

3.  Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

Authors:  Lin Pei; Frank J S Lee; Anna Moszczynska; Brian Vukusic; Fang Liu
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

4.  A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release.

Authors:  J Harvey; M G Lacey
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 5.  Adenosine A2A receptors and basal ganglia physiology.

Authors:  S N Schiffmann; G Fisone; R Moresco; R A Cunha; S Ferré
Journal:  Prog Neurobiol       Date:  2007-06-26       Impact factor: 11.685

6.  Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.

Authors:  Sarah Threlfell; Stephen Sammut; Frank S Menniti; Christopher J Schmidt; Anthony R West
Journal:  J Pharmacol Exp Ther       Date:  2008-12-04       Impact factor: 4.030

Review 7.  Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase.

Authors:  Ted Abel; Peter V Nguyen
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

8.  D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance.

Authors:  S Hernández-López; J Bargas; D J Surmeier; A Reyes; E Galarraga
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

9.  GABAb receptors regulate chick retinal calcium waves.

Authors:  M Catsicas; P Mobbs
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

10.  Forskolin Enhances Synaptic Transmission in Rat Dorsal Striatum through NMDA Receptors and PKA in Different Phases.

Authors:  Hyeong Seok Cho; Hyun Ho Lee; Se Joon Choi; Ki Jung Kim; Seung Hyun Jeun; Qing-Zhong Li; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2008-12-31       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.